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Flavonoids, plant secondary metabolites present in fruits, vegetables, and products such as tea and red wine, show antioxidant,
anti-inflammatory, antithrombotic, antiviral, and antitumor activity. PDIA3 is a member of the protein disulfide isomerase family
mainly involved in the correct folding of newly synthetized glycoproteins. PDIA3 is associated with different human pathologies
such as cancer, prion disorders, Alzheimer’s disease, and Parkinson’s diseases and it has the potential to be a pharmacological target.
The interaction of different flavonoids with PDIA3 was investigated by quenching fluorescence analysis and the effects on protein
activity were evaluated. A higher affinity was observed for eupatorin-5-methyl ether and eupatorin which also inhibit reductase
activity of PDIA3 but do not significantly affect itsDNAbinding activity.Theuse of several flavonoids differing in chemical structure
and functional groups allows us to make some consideration about the relationship between ligand structure and the affinity for
PDIA3. The specific flavone backbone conformation and the degree of polarity seem to play an important role for the interaction
with PDIA3.Thebinding site is probably similar but not equivalent to that of green tea catechins, which, as previously demonstrated,
can bind to PDIA3 and prevent its interaction with DNA.
1. Introduction
PDIA3/ERp57 is a member of the protein disulfide isomerase
family mainly present in the endoplasmic reticulum, where
it carries out a major role as a key molecular player in the
quality control and correct folding of newly synthesized gly-
coproteins [1]. However, PDIA3 has been found in different
subcellular compartments where it has been proposed and
sometimes proved to be involved in a remarkable variety of
cellular processes and in pathological conditions including
cancer and neurodegenerative diseases. This is documented
by the evergrowing number of published results summarized
in some recent reviews [2–4].
The specific enzymatic activity and wide binding capa-
bilities of PDIA3 may allow its interaction with many other
proteins. PDIA3 has been thought to be a participant in
the mechanisms of cell protection against oxidative stress
through its redox and chaperone activities but target sub-
strates remain to be ascertained. Many studies suggest that
PDIA3 can prevent oxidation of thiol residues and aggre-
gation of target proteins which might result in a loss of
functional and/or structural properties [5–7]. Expression
of PDIA3 is increased in more than 70% of cancers and
its expression has been associated with cell invasiveness,
metastasis, and low overall survival. PDIA3 may play a role
in the oncogenic transformation as a result of its ability to
control intracellular and extracellular redox state via thiol-
dependent reductase activity [8, 9]. Moreover, PDIA3 may
be engaged in cellular signalling pathways involving reactive
oxygen species: it may rescue the functional activity of target
proteins that undergo redox modification and/or control
the formation of macromolecular complexes involved in the
adaptive response to oxidative stress.
In this contest, the identification of specific substances
able to bind PDIA3 and to modify its properties will be
very useful. Considering the high level of PDIA3 expression
in several cancer types, specific inhibitors might offer new
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therapeutic tools, while the identification of ligands that
can modulate and/or inhibit PDIA3 interaction with specific
partnersmay be useful to selectively control cellular processes
and signalling pathways involving PDIA3.
Flavonoids are a large class of polyphenolic compounds
ubiquitous in plants and mostly present in fruits, vegeta-
bles, and plant-based beverages such as tea and wine [10].
Flavonoids are further subclassified in to flavones, flavonols,
isoflavones, flavanones, flavanols, and anthocyanidins [11, 12]
(Figure 1).These physiologically active compounds, which are
produced via secondary metabolism, have well-known mul-
tiple health beneficial effects. Many studies have suggested an
association between consumption of flavonoids-rich food or
beverages and the prevention of many degenerative diseases,
including cancer, neurodegeneration, and coronary heart
disease and stroke [13–17]. Therefore, flavonoids represent
one of the most attracting families of natural bioactive
molecules and important components of a normal human
diet.
The protection offered by flavonoids is believed to be
due to their antioxidant activity. The aromatic rings of the
flavonoid molecule allow the donation and acceptance of
electrons from free radical species [18]. In addition, many
polyphenols regenerate the traditional antioxidant vitamins,
vitamin C and vitamin E [19], and act as metal chelators [20].
This latter property contributes to their antioxidant effects
through the inhibition of free radical formation catalysed by
transition metals [21]. However, the concentrations at which
they can exert such antioxidant activity are unlikely achieved
in vivo, as many of them have limited bioavailability and are
extensively metabolized [22, 23].
It has been suggested that, in lower amounts, flavonoids
as well as polyphenols may exert pharmacological activity
within the cells, having the potential to modulate intra-
cellular signalling pathways. Many polyphenols can induce
antioxidant enzymes such as glutathione peroxidase, catalase,
and superoxide dismutase and inhibit the expression of
enzymes such as xanthine oxidase, which is involved in the
generation of free radicals [24, 25]. However, for many of
them the molecular and cellular bases of these activities are
not well known. They can act by different targets including
the regulation of cell signalling and the cell cycle, free
radical scavenging, inhibition of angiogenesis, initiation of
DNA repairmechanisms, apoptotic induction, and inhibition
of metastasis. By affecting such pathways flavonoids have
the ability to control cell proliferation and survival and to
exhibit antiproliferative and antimutagenic properties and a
remarkable anti-inflammatory activity [26–29].
Given the involvement of PDIA3 in the cellular response
to stress as well as in cancer and neurodegeneration, we
felt it is useful to undertake a screening study for assessing
the interaction and impact on PDIA3 protein activity of
several types of flavonoids. This study, which initially started
analyzing the major catechins present in the extracts of green
tea [30], has been expanded to various classes of flavonoids
to verify if their activity was in some way connected to the
modulation of PDIA3 functions.
The binding of several flavonoids to PDIA3 and their
effects on the protein were tested by protein fluorescence
quenching and differential scanning fluorimetry. Protein
redox and DNA binding activities were also analyzed in
the presence of flavonoids, with the aim to find specific
molecules useful to control/modulate the cellular processes
and signalling pathways involving the PDIA3 protein and to
check for any relationship between the polyphenolic structure
and the interaction with the protein.
2. Material and Methods
2.1. Chemicals. PBS solution, acrylamide, N-ethylmaleimide,
DTT, GSSG, eosin isothiocyanate, and 19 different flavonoids
(quercetin, 3-O-methyl quercetin, isoquercetin, quercitrin,
rutin, morin, rhamnetin, isorhamnetin, fisetin, apigenin,
apigenin-7-glucoside, luteolin-7-glucoside, kaempferol, eupa-
torin, eupatorin-5-methyl-ether, genistein, naringenin, cyani-
din, and 6,2󸀠,4󸀠-trimethoxyflavone) were purchased from
Sigma-Aldrich, EDTA (0.5M solution pH 8.0) from IBI
Scientific. SYPRO Orange was from Invitrogen.
2.2. Protein Expression and Purification. Human recombi-
nant PDIA3 was cloned and expressed in E. coli strain BL21
using the expression vector pET21 (Novagen) as previously
described [33]. The coding sequence for the second redox-
active domain (𝑎󸀠 domain, residues 377–505) was amplified
by PCR as previously described and cloned in the expression
vector pET29 (Novagen) [34]. Recombinant proteins were
expressed in E. coli strain BL21 and purified by ammonium
sulphate fractionation, ion exchange, and heparin chro-
matography [34, 35]. Protein purification was evaluated by
SDS-PAGE and concentration was determined spectropho-
tometrically (PDIA3 @280 reduced form = 44,810M
−1 cm−1;𝑎󸀠 domain @280 reduced form = 14,400M−1 cm−1).
2.3. FluorescenceQuenchingMeasurements. Quantitative anal-
ysis of the interaction between individual flavonoids and
PDIA3 was performed by fluorimetric titration. Fluores-
cence spectra were recorded using a SPEX-FluoroMax spec-
trofluorimeter (Horiba Scientific) from 300 to 500 nm with
excitation at 290 nm using a 10mm path length quartz
fluorescence cuvette and under continuous stirring. The
excitation and emission slits were both set to 5 nm and
scan speed was 120 nm⋅min−1. Briefly, solution of PDIA3
(0.5 𝜇M) or 𝑎 and 𝑎󸀠 domains (1 𝜇M) in phosphate buffered
saline (PBS) containing DTT 0.1mM and EDTA 0.2mM
were titrated in quartz cuvette by stepwise additions, at
5min time intervals, of individual flavonoid solution (1mM
in PBS/ethanol 50 : 50 v/v freshly prepared from a 20mM
stock solution in DMSO). Most of tested flavonoids can
absorb light at the excitation and emission wavelengths.
To minimize the inner-filter effect we limited the highest
concentration reached in the titration test up to 10𝜇M.
All experiments were carried out at 25∘C. Each spectrum
was the mean of three repeated scans. Fluorescence spectra
of appropriate blanks (flavonoids without proteins) were
recorded under the same experimental conditions and sub-
tracted from the corresponding flavonoid-protein system to
correct the fluorescence background. Fluorescence intensities
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Figure 1: Flavonoid structures and occurrence. Arrows indicate biosynthetic path.
recorded at 338 nmwere used for quenching analysis and data
obtained for each flavonoid are the average of at least three
independent titration experiments.
2.4. Differential Scanning Fluorimetry. Protein stability was
tested by the fluorescence-based thermal stability assay or
differential scanning fluorimetry (DSF) developed by Pan-
toliano and coworkers [36]. DSF records the fluorescence
emission signal from the binding of a dye (SYPRO orange)
to the exposed hydrophobic patches upon protein unfolding.
Fluorescence measurements were performed using a CFX96
Connect RT-PCR instrument (BioRad). 18 𝜇l aliquots of
protein solution (1 𝜇M), freshly diluted in Tris Buffered
saline (50mM TrisHCl, pH 8.0, 150mM NaCl) containing
0.1mM DTT, 0.2mM EDTA, and 1 : 1000 dilution of SYPRO
Orange (50mM stock solution in DMSO), were distributed
in a 96-well plate. Sample wells were addition of increasing
concentration (up to 50𝜇M) of individual flavonoid by
adding 2 𝜇l of 10-fold concentrated stock solutions freshly
prepared. As control, the protein solution was added with
2 𝜇l of the dilution buffer. A melting point analysis was
recorded increasing the temperature from 20 to 95∘C with
an increment of 0.5∘C and reading, at each temperature, the
fluorescence in fluorescence resonance energy transfer mode
(FRET). Each measure was the average of three sample wells
reading and each DSF experiment was repeated at least three
times. To calculate 𝑇𝑚 values, DSF data from the melting
curve were exported and fitted to Boltzman equation using
GraphPad software [37]. Effect of flavonoids was evaluated
comparing the 𝑇𝑚 values in presence and absence of each
molecule.
2.5. Determination of Protein Disulfide Reductase Activity.
Disulfide reductase activity of ERp57 was monitored by
sensitive fluorescent assay using dieosin glutathione disul-
fide (DiE-GSSG) as fluorogenic probe [38]. DiE-GSSG was
synthesized by the reaction of eosin isothiocyanate with
oxidized glutathione (GSSG) according to the method of
Raturi and Mutus [38] with some modifications [30]. DiE-
GSSG concentration was determined spectrophotometrically
(@525 = 88,000M
−1 cm−1). Disulfide reductase activity was
assayed in a reaction buffer containing 2mM EDTA, 150 nM
DiE-GSSG, and 5 𝜇M DTT in PBS. A 20𝜇l aliquot of a
stock solution of PDIA3 (1 𝜇M) was added to the reaction
mixture and DiE-GSSG reduction was monitored at 545 nm
with excitation at 520 nm, at 25∘C with continuous stirring.
Reductase activity was calculated as the initial velocity in
fluorescence increase. To test the effect of flavonoids on
PDIA3 activity, the protein stock solution was previously
incubated for 15 minutes at room temperature with different
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concentrations of each flavonoid and then a 20𝜇l aliquot
subjected to assay in a reaction buffer containing the same
concentration of the flavonoid.
2.6. Determination of DNABinding Activity by EMSA. EMSA
assay was performed using a 79-bp rich DNA fragment
obtained by PCR as previously described [39]. Ampli-
fied DNA was end-labeled by using 5-fluorescein-modified
primers. 10 ng of DNA fragment was incubated with 1𝜇g of
PDIA3 or 𝑎󸀠 domain, in presence of increasing concentration
of flavonoids (from 0 to 50 𝜇M). Controls were performed
using DNA alone and in the presence of each flavonoid. All
tests were performed in 20𝜇l mixtures containing 20mM
Tris-HCl, pH 7.5, 50mM NaCl, and 10% (v/v) glycerol.
Samples were incubated for 1 hour at 25∘C and then resolved
on 5% polyacrylamide gels in 0,25% TBE buffer (22.5mM
Tris-borate, 5mM EDTA, pH 8.3) at 150 V. Gel images were
recorded using a ChemiDoc MP Imaging System (BioRad)
equipped with an epi-blue excitation lamp and a 520 nm
emission filter.
2.7. Statistical Analysis. Fluorescence quenching constant
(𝐾SV) values were given as means ± standard deviation
and values of disulfide reductase activity were expressed
in % of control sample ± relative standard deviation. All
measurements were performed at least three times. Dunnett’s
test was used to compare the obtained reductase activity data
with the activity of the untreated protein and a 𝑝 value of<0.01 was considered as statistically significant.
2.8. Other Procedures. Proteins were analyzed by SDS-PAGE.
Samples were added with 10mM N-ethylmaleimide before
dilution with concentrated SDS-sample buffer to prevent any
reactivity of free thiol groups.
3. Results and Discussion
3.1. Study of the Flavonoids-PDIA3 Interaction by Fluorescence
Analysis. We started a screening analysis to find molecules
which specifically bind PDIA3 and can inhibit its redox
activity and/or the binding to other proteins or DNA
sequences [30]. Such substances could be useful to modulate
the biological functions of PDIA3. In this study the inter-
action of different flavonoids with PDIA3 and their effects
on protein reductase activity were evaluated. A number of
flavonoids, comprehending flavones, flavonols, and several
derivatives, which differ in terms of skeleton structure as
well as hydroxyl, methoxyl, and other substituted groups,
were analyzed (Figure 2). The interaction was investigated by
quenching analysis of PDIA3 intrinsic fluorescence mainly
due to the presence of three tryptophan residues. They differ
from each other in solvent or quencher accessibility and
can unequally contribute to the protein fluorescence. One
tryptophan residue (W279) is buried in a hydrophobic pocket
in the 𝑏󸀠 domain whereas the other two (W56 andW405) are
present on the protein surface close to the thioredoxin-like
active sites within 𝑎 and 𝑎󸀠 domains, respectively.
Quenching analysis was performed on PDIA3 (0.5 𝜇M),
in the reduced form, by adding stepwise increasing concen-
tration of each molecule and recording the protein fluores-
cence spectra. For some flavonoids the analysis was extended
to isolate 𝑎󸀠 domain (1 𝜇M), always in the reduced form.
Quenching effect on protein and Stern-Volmer quenching
constant (𝐾SV) were calculated from the fluorescence inten-
sities at 338 nm of protein alone (𝐹0) and in the presence of
increasing concentration of each ligand molecule (𝐹) using
the Stern-Volmer equation [40]:
𝐹0𝐹 = 1 + 𝐾SV [𝐿] , (1)
where 𝐿 is the ligand concentration. For each ligandmolecule
the Stern-Volmer quenching constant was obtained by linear
regression of plots of 𝐹0/𝐹 versus [𝐿].
Representative fluorescence spectra of PDIA3 in the
presence of increasing concentration of eupatorin are showed
in Figure 3(a). A different degree of quenching was observed
in presence of tested molecules. The decrease of fluorescence
may indicate that the microenvironments of tryptophan
residues in PDIA3 were altered due to the interaction with
tested compounds. No evident spectral shift was noticed in
fluorescence spectra of PDIA3 after the additions of all tested
flavonoids, suggesting that these substances do not induce
any evident change in protein conformation.
Fluorescence quenching data were analyzed using the
Stern-Volmer equation. The Stern-Volmer plot for PDIA3, in
presence of eupatorin, is displayed in Figure 3(b) while the
estimated𝐾SV values of all tested flavonoids are summarized
in Table 1 and graphed in Figure 4.
The Stern-Volmer quenching constant may be expressed
as 𝐾SV = 𝐾𝑞𝜏0, where 𝐾𝑞 is the quencher rate coefficient
and 𝜏0 is the average lifetime of the emissive excited state
of the protein in the absence of the quencher. Based on a
typical value of 𝜏0 of the order of 10−8 s [40, 41], the values
of 𝐾𝑞 can be estimated and are reported in Table 1. The
values of 𝐾𝑞 observed for flavonoids-PDIA3 interaction are
much greater than 2.0 × 1010M−1 s−1, themaximumdiffusion
collision quenching rate constant reported for the interaction
of various kinds of quencher with proteins [42], suggesting
that the quenching is not the result of a dynamic collision
but it occurs via formation of complexes between the protein
and flavonoids.This interaction should involve regions of the
protein near the two tryptophan residues, W56 and W405,
more exposed to the solvent and close to the redox-active
sites.
In static quenching, various equations expressing the
relationship between fluorescence intensity and quencher
concentration have been described for the evaluation of the
binding constant and the number of binding sites. However,
the analysis of protein-ligand binding, using fluorescence
quenching, may be affected by a number of pitfalls that
cannot be easily overcome.
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Table 1: Stern-Volmer constant (𝐾SV), bimolecular quenching rate constant (𝐾𝑞), number of binding sites (𝑛), binding constant (𝐾𝑏), and
dissociation constant (𝐾𝑑) of several flavonoid-PDIA3 systems.
Flavonoid 𝐾SV (M−1) 𝐾𝑞 (M−1 s−1) 𝑛 𝐾𝑏 (M−1) 𝐾𝑑 (M)
Flavone
Trimethoxyflavone 22209 ± 484 2.22 ⋅ 1012 0.90 1, 81 ⋅ 104 5.52 ⋅ 10−5
Eupatorin-5-methyl ether 90016 ± 1875 9.00 ⋅ 1012 1.08 9.04 ⋅ 104 1.11 ⋅ 10−5
Eupatorin 89362 ± 688 8.94 ⋅ 1012 1.16 9.67 ⋅ 104 1.03 ⋅ 10−5
Apigenin 54332 ± 1185 5.43 ⋅ 1012 1.08 5.87 ⋅ 104 1.70 ⋅ 10−5
Apigenin-7-glucoside 43961 ± 673 4.40 ⋅ 1012 1.06 4.73 ⋅ 104 2.11 ⋅ 10−5
Luteolin-7-glucoside 31601 ± 484 3.16 ⋅ 1012 1.06 3.46 ⋅ 104 2.89 ⋅ 10−5
Flavanone
Naringenin 16900 ± 352 1.69 ⋅ 1012 1.05 1.73 ⋅ 104 5.78 ⋅ 10−5
Isoflavone
Genistein 22953 ± 435 2.30 ⋅ 1012 1.09 2.44 ⋅ 104 4.10 ⋅ 10−5
Flavonol
Rhamnetin 28462 ± 295 2.85 ⋅ 1012 1.03 3.01 ⋅ 104 3.32 ⋅ 10−5
Isorhamnetin 36109 ± 1271 3.61 ⋅ 1012 0.96 3.25 ⋅ 104 3.08 ⋅ 10−5
3-O-Methyl-quercetin 41110 ± 794 4.11 ⋅ 1012 1.09 4.57 ⋅ 104 2.19 ⋅ 10−5
Fisetin 33164 ± 542 3.32 ⋅ 1012 1.08 3.67 ⋅ 104 2.71 ⋅ 10−5
Kaempferol 28423 ± 982 2.84 ⋅ 1012 0.97 2.60 ⋅ 104 3.85 ⋅ 10−5
Morin 24063 ± 265 2.41 ⋅ 1012 1.04 2.56 ⋅ 104 3.90 ⋅ 10−5
Quercetin 46226 ± 1406 4.62 ⋅ 1012 0.88 3.90 ⋅ 104 2.56 ⋅ 10−5
Quercitrin 29211 ± 483 2.92 ⋅ 1012 1.07 3.23 ⋅ 104 3.10 ⋅ 10−5
Isoquercetin 25738 ± 367 2.57 ⋅ 1012 1.08 2.91 ⋅ 104 3.44 ⋅ 10−5
Rutin 45197 ± 465 4.52 ⋅ 1012 0.96 4.55 ⋅ 104 2.20 ⋅ 10−5
Anthocyanin
Cyanidin 29761 ± 635 2.98 ⋅ 1012 0.99 2.93 ⋅ 104 3.42 ⋅ 10−5
Data were calculate from fluorescence quenching analysis using 0.5 ∗ 10−6M PDIA3 in reduced conditions (pH 7.4, 25∘C) and increasing concentration (0 to
10 ∗ 10−6M) of different flavonoids.𝐾SV are reported as mean and standard deviation of at least three independent experiments. The number of binding sites
(𝑛), the binding constant (𝐾𝑏), and the dissociation constant (𝐾𝑑) were estimated using the equation described by Bi et al. [31] and the reiterative calculation
process described by Sun et al. [32].
The apparent binding constants (𝐾𝑏) and the number of
binding sites (𝑛) were calculated using the equation described
by Bi et al. [31], as previously reported [30]:
log(𝐹0 − 𝐹𝐹 )
= 𝑛 log𝐾𝑏 − 𝑛 log( 1[𝐿 𝑡] − 𝑛 (𝐹0 − 𝐹) [𝑃𝑡] /𝐹0) ,
(2)
where 𝐹0 and 𝐹 are the fluorescence intensities at 338 nm
before and after the addition of the quencher and [𝐿] and
[𝑃𝑡] are the ligand and the total protein concentrations,
respectively. The number of binding sites (𝑛) and the binding
constant (𝐾𝑏) were obtained by plotting log((𝐹0 − 𝐹)/𝐹)
versus log(1/([𝐿 𝑡] − 𝑛(𝐹0 − 𝐹)[𝑃𝑡]/𝐹0)) using the reiterative
calculation process described by Sun et al. [32], assuming
a similar affinity for each binding site. The dissociation
constant was calculated from the binding constant (𝐾𝑑 =1/𝐾𝑏).
The estimated 𝐾SV, 𝐾𝑏, and 𝐾𝑑 values that characterize
the interaction of PDIA3 with tested flavonoids are sum-
marized in Table 1. Although the protein can bind most
of the tested substances, with an estimated dissociation
constant within the 10−5M range, some of them showed a
better affinity.Molecules characterized by the highest binding
constants are eupatorin and eupatorin-5-methyl ether, with a𝐾𝑑 around 1.0 × 10−5M, followed by apigenin, with a𝐾𝑑 of 1.7× 10−5M.
The use of several flavonoids differing in chemical
structure and functional groups allows us to make some
considerations about the ligand structures and their affinity
for PDIA3. Comparing the structure of the molecules with
higher affinity, they share the same basic flavone backbone:
eupatorin-5-methyl ether and eupatorin are characterized by
the presence of both hydroxyl- and methoxyl- groups, while
the flavone apigenin that has only hydroxyl groups, two on
the A ring and one on the B ring, has a lower affinity. 6,2󸀠,4󸀠-
Trimethoxyflavone, a flavone with only methoxyl groups,
showed the lowest affinity for the protein. In this respect,
the specific degree of polarity of the flavone backbone seems
to play an important role for the interaction with PDIA3.
The addition of a sugar moiety, like glucose in apigenin-
7-glucoside, negatively affects the binding compared to
apigenin. The affinity is even lower analyzing luteolin-7-
glucoside, which has one more hydroxyl group on the B
ring. These observations suggest that a specific degree of
6 Oxidative Medicine and Cellular Longevity
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Figure 2: Molecular structure of tested flavonoids.
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fluorescence quenching analysis of reduced PDIA3 [0.5 × 10−6M]
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hydrophilicity is required to stabilize the interaction of the
flavone backbone with the protein.
Apigenin, genistein, and naringenin share similar func-
tional groups but differ for the position and orientation of
the B ring. In naringenin the B ring on the C2 position is
differently oriented with respect to A and C rings while it
is also differently positioned (C3) in genistein (3D models
of default conformers are shown in Figure 5). The flavanon
naringenin showed a much lower binding affinity compared
to apigenin; hence, it can be hypothesized that the more
A ring B ring
Naringenin
Genistein
Apigenin
Figure 5: 3D models of default conformers for apigenin (CID
5280443), genistein (CID 5280961), and naringenin (CID 932)
generated by PubChem (https://pubchem.ncbi.nlm.nih.gov/).
parallel orientation between the aromatic rings A and B,
mainly evident in flavones, is an important feature to the
binding to PDIA3. The isoflavone genistein also showed
a lower affinity compared to apigenin, stressing out the
importance of a specific position and orientation of the B ring
for the interaction with PDIA3.
The analysis of different flavonols showed dissociation
constants between 2.0 × 10−5M and 4.0 × 10−5M. Flavonols,
different from flavones, are characterized by a B ring that,
in the most stable conformation, is almost perpendicular to
the A ring due to the presence of a hydroxyl group linked
to the C3 position; this may explain their lower affinity. As
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above reported for flavons, we can observe some differences
in the affinity within the analyzed flavonol. Among flavonols
sharing only hydroxyl groups as substituents, quercetin and
fisetin showed a slight better affinity compared to kaempferol
and morin. These flavonols differ in the specific position of
hydroxyl groups, and it could be hypothesized that a hydroxyl
group sited at 5 positions on A ring and unsubstituted
C2
󸀠
hydroxyl group on B ring have a positive effect on
the dissociation constant. Flavonols with a similar structure
but characterized by the presence of a methoxyl group in
three different positions (rhamnetin, isorhamnetin, and 3-O-
methyl quercetin, with the –OCH3 group sited on the A, B,
and C rings, resp.) differently bind PDIA3, with 3-O-methyl
quercetin showing a higher affinity with respect to rhamnetin
and isorhamnetin. Therefore, beside the orientation of aro-
matic rings, the specific distribution of functional groups on
the flavonol backbone structure plays an important role to
stabilize the interaction with the protein.
Finally, the effect on the flavonoid-PDIA3 binding of a
sugar moiety, linked to the backbone structure, was tested.
As above reported, the presence of a glucose moiety on the
C7 position has a negative effect on the binding of flavones
apigenin-7-glucoside and luteolin-7-glucoside compared to
the unglycosylated form. For flavonols we observed a similar
behavior. In fact, the addition of a single carbohydrate linked
to the C3 position (isoquercetin and quercitrin) lowers the
binding affinity for the protein compared to quercetin, the
corresponding unglycosylated flavonoid. Thus, the presence
of a carbohydrate moiety has a negative effect on the binding
to the PDIA3 protein, probably because this increases the
polarity of one side of the flavonoid molecule. In fact, as
above emphasized, the flavonoids showing the best affinity are
eupatorin and eupatorin-5-methyl ether, both characterized
by a specific degree of polarity, with few hydroxyl groups and
a larger number of methoxyl groups, uniformly distributed
around the backbone structure. However, increasing the
number of carbohydrate linked to the C3 position raises the
affinity as results in the similar binding properties of rutin
and quercetin. This positive effect may be the result of an
increased size of themolecule and the number of interactions
that can be established with the protein.
For some flavonoids, the binding analysis was extended
to the isolated 𝑎󸀠 domain. Similar values for the binding
constants were estimated, with some flavonoids showing a
slightly better affinity for the whole protein respect to the
isolated domain. Even in this case, the molecules that show
the greatest affinity are the flavones eupatorin, eupatorin-
5-methyl ether, and apigenin (data not shown). PDIA3 and
the homologous isoform PDIA1, although similar in overall
domain structure and active-site motifs, carry out different
functions that are the result of specialized substrate binding
properties. These differences are mainly related to the C-
terminal domains 𝑏󸀠 and 𝑎󸀠 that show the lowest homology
between the two isoforms [43, 44]. Our findings indicate that
flavonoids can effectively bind the PDIA3 isoform through
its C-terminal 𝑎󸀠 domain, as we previously reported for
galloylated catechins [30].
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Figure 6: Increase inmelting temperature (𝑇𝑚) of PDIA3 calculated
by differential scanning fluorimetry of reduced PDIA3 [1 × 10−6M]
in presence of indicated concentrations of selected flavonoids. Plots
are displayed as mean and standard deviations of at least three
independent measurements.
Fluorescence quenching data suggest that flavonoids’
interaction with the protein involves mainly the tryptophan
residues near to the redox-active sites. Although PDIA3
contains two redox-active domains, both potentially able to
interact, data analysis estimates a single binding site for each
molecule. It could be possible that differences in the affinity
of the two binding sites introduce a further pitfall in math
calculation of binding stoichiometry. However, as previously
hypothesized for catechins-PDIA3 interaction, we suggest
that the binding of the first molecule to one of the redox
domain prevents the binding of a second molecule to the
other redox domain, as a result of steric hindrance and/or
changes in the local environment that hinder the second site
[30].
3.2. Effect of Flavonoids on the PDIA3 Stability. The effect
of flavonoids on the protein stability was evaluated by DSF.
Most of the tested molecules showed no or limited effect,
but quercetin, morin, kaempferol, and fisetin can stabilize
the protein in a concentration-dependent manner. The 𝑇𝑚
value calculated for PDIA3 by scanning fluorimetry was
increased more than three degrees at 50𝜇M concentra-
tion of these flavonoids (Figure 6). Apigenin, isorhamnetin,
rhamnetin, genistein, and cyanidin produced a similar, but
less pronounced, effect and mainly at the highest concen-
tration. Quercetin, morin, kaempferol, and fisetin, even if
characterized by a lower affinity compared to the flavones
eupatorin and eupatorin-5-methyl ether, share a protective
effect against thermal denaturation. This may be the result of
their specific structure, rich in hydroxyl groups distributed
around the flavonol backbone; in fact, the stabilizing effect
of polyols on protein structure has been widely described
[45, 46]. Glycosylated flavonoids do not seem to have such
stabilizing properties, probably because of their different size
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Figure 7: Comparison of flavonoid effect (at 20 𝜇M concentration)
on PDIA3 reductase activity. Plots are displayed as mean and
standard deviations of at least six independent measurements.
Data were analyzed by Dunnett’s test comparing PDIA3 activity in
presence of each flavonoid with the activity of untreated protein.
Significant differences (𝑝 < 0.01) are marked with asterisks.
and solubility that may change the interaction with protein
and solvent.
3.3. Effect of Flavonoids on the PDIA3 Redox Activity. To
verify if the interaction between flavonoids and PDIA3 may
have an effect on protein functions, the disulfide reductase
activity was tested. For most of the molecules analyzed the
effect on the redox activity of the proteinwas negligible.How-
ever, some flavonoids, in particular the flavones eupatorin
and eupatorin-5-methyl ether, showed an evident inhibitory
effect, up to 40%. Others, such as morin, quercetin, and
cyanidin, had a less marked inhibition, approximately 20%
(Figure 7). Apigenin, which showed a binding affinity close to
eupatorin, had no evident effect on the protein activity. It is
possible that the less polar degree that characterizes eupatorin
and eupatorin-5-methyl ether may play a significant role. It
should be also noted that more hydrophilic molecules like
morin, quercetin, and cyanidin share a certain inhibitory
effect indicating a more complex pattern of interaction with
the protein. On the basis of these results, we hypothesize
that, at least for thosemolecules showing amarked inhibitory
effect on redox activity, the contact region of interaction
between the flavonoid structure and PDIA3 should involve
the active site. However, since we used a simple substrate like
DiE-GSSG to measure the redox activity, we cannot exclude
that the inhibitory effect of all flavonoids could be different
towards more physiological substrates.
3.4. Effect of Flavonoids on the DNA Binding Property of
PDIA3. We also evaluated by EMSA analysis the effect of
all analyzed flavonoids on the DNA binding property of the
protein. None of tested flavonoids showed an appreciable
effect on the DNA binding activity of the protein, different
from what previously reported for galloylated catechins [30].
In that case, we hypothesized that the galloyl moiety on
the C3 position could prevent the DNA binding activity
interacting with a 𝛽-strand region close to the redox-active
site. Upon protein oxidation, such region can undergo to a
conformational change that is essential for the interaction
with the DNA [34]. In this report none of the molecules
analyzed have such effect. As proposed above, we suggest
that flavonoids interact with the same protein region con-
taining the tryptophan residues close to the active sites.
However, this interaction may differently extend depending
on the flavonoid structure and on specific contacts between
flavonoids functional groups and amino acidic residues on
the protein surface.
4. Conclusions
The interaction of different flavonoids with PDIA3 and their
effect on protein reductase activity were evaluated in a com-
parative analysis of protein intrinsic fluorescence quench-
ing. Eupatorin and eupatorin-5-methyl ether, flavones both
characterized by a mild polarity for the presence of several
methoxyl groups, showed the highest affinity for PDIA3 with
a 𝐾𝑑 near to 1.0 × 10−5M. The same molecules showed a
noticeable inhibitory effect on disulphide reductase activity
of PDIA3 but did not significantly affect its DNA binding
activity. The flavone backbone structure is characterized by
a more stable conformation where B and A rings are almost
parallel (Figure 8). This structure, associated with a definite
degree of polarity, due to the presence of several methoxyl
groups, seems to be an important feature to determine a good
affinity towards PDIA3. On the other hands, flavonols, which
are characterized by aB ringmainly positioned perpendicular
to the A ring, share a lower affinity. Therefore, the different
orientation of the B ring can modify the interaction with the
protein. Our data suggest that, different from what observed
for flavones, the binding of flavonols varies on the basis of the
presence and specific position of functional groups linked to
the backbone. Only morin and quercetin, among flavonols,
showed some inhibitory effect on PDIA3 redox activity even
if to a lesser extent than flavones eupatorin and eupatorin-5-
methyl ether. None of tested molecules prevent the binding
of PDIA3 to DNA.
We can hypothesize that flavones and flavonols interact
with a similar region of the protein involving the tryptophan
residues close to the redox site. Given that PDIA3 does not
contain any evident deep cavity or slot where this kind of
ligands can bind, the binding of flavonoids may occur mainly
via a flat interaction with the protein surface. Therefore, the
planarity of the molecule as well as the number and specific
position of its functional groups (hydroxyl, methoxyl, and
carbohydrates) will definitively play amajor role to determine
the affinity for the protein. This binding site is probably
similar but not equivalent to that of green tea galloylated
catechins, which, as previously reported, can bind to PDIA3
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Figure 8: 3D models of default conformers for eupatorin (CID 97214), quercetin (CID 5280343), and epigallocatechin gallate (CID 65064)
generated by PubChem. The estimated 𝐾𝑑 values that characterize the interaction of PDIA3 with the three flavonoids, the percentage of
inhibition of protein redox activity, and the effect on DNA binding are also reported (epigallocatechin gallate data were from Trnkova´ et al.
[30]).
and to its isolated 𝑎󸀠 domain and prevent the interaction
with DNA [30]. The presence in these molecules of a galloyl
moiety linked to the C3 position is probably responsible
for a different type of interaction that may extend to a
protein region important to the contact with DNA (Fig-
ure 8). Another polyphenolic compound, the flavonolignan
silibinin, has been previously showed to bind PDIA3 with a
dissociation constant withinmicromolar range [47]. Silibinin
higher affinity may be explained by its larger size that allows
a better interaction with the surface of the protein. Since
silibinin has no effect on the redox activity and DNA binding
capability of PDIA3, we can expect that its binding involves a
further different region close to the active site.
In conclusion, eupatorin and eupatorin-5-methyl ether
represent leading compounds for the binding to PDIA3 and
for the inhibition of its redox activity. Further experiments
are required to better characterize the effect of flavonoids on
PDIA3 and to understand if some of the biological activities
of these compounds are depending on the interaction with
PDIA3. Previously studies showed that eupatorin exhibits
antiproliferative activity and apoptosis induction preferen-
tially in cancer cells [48, 49]. In addition, eupatorin behaves
as nonspecific inhibitor of several protein kinases, but its anti-
cancer effect can also depend on the ability to interfere with
angiogenesis through inhibition of VEGFRs [50]. A recent
study provides evidence regarding antiproliferative action of
eupatorin-5-methyl ether through a pathway that involves
activation of CYP1 enzymes [51]. Although previous reports
demonstrated antitumor properties of eupatorin-5-methyl
ether, the mechanism of action remains poorly understood
[52]. Since these flavones and PDIA3 are both involved in
proliferative and carcinogenic processes, our in vitro findings
on their interaction suggest that some of the biological effects
of flavones can be mediated by modulation of PDIA3 activity.
Additionally, this study will help to define and identify
compounds to be used as selective inhibitors/modulators of
PDIA3 biological activities.
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